Literature DB >> 29808576

Bioinspired Diselenide-Bridged Mesoporous Silica Nanoparticles for Dual-Responsive Protein Delivery.

Dan Shao1,2,3, Mingqiang Li1, Zheng Wang2, Xiao Zheng3, Yeh-Hsing Lao1, Zhimin Chang2, Fan Zhang3, Mengmeng Lu1, Juan Yue2, Hanze Hu1, Huize Yan1, Li Chen3, Wen-Fei Dong2, Kam W Leong4.   

Abstract

Controlled delivery of protein therapeutics remains a challenge. Here, the inclusion of diselenide-bond-containing organosilica moieties into the framework of silica to fabricate biodegradable mesoporous silica nanoparticles (MSNs) with oxidative and redox dual-responsiveness is reported. These diselenide-bridged MSNs can encapsulate cytotoxic RNase A into the 8-10 nm internal pores via electrostatic interaction and release the payload via a matrix-degradation controlled mechanism upon exposure to oxidative or redox conditions. After surface cloaking with cancer-cell-derived membrane fragments, these bioinspired RNase A-loaded MSNs exhibit homologous targeting and immune-invasion characteristics inherited from the source cancer cells. The efficient in vitro and in vivo anti-cancer performance, which includes increased blood circulation time and enhanced tumor accumulation along with low toxicity, suggests that these cell-membrane-coated, dual-responsive degradable MSNs represent a promising platform for the delivery of bio-macromolecules such as protein and nucleic acid therapeutics.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  biodegradable mesoporous silica nanoparticles; cancer-cell-membrane cloaking; diselenide; dual-responsive; protein delivery

Year:  2018        PMID: 29808576     DOI: 10.1002/adma.201801198

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  43 in total

1.  Transient Receptor Potential Ion Channel-Dependent Toxicity of Silica Nanoparticles and Poly(amido amine) Dendrimers.

Authors:  Raziye Mohammadpour; Mostafa Yazdimamaghani; Christopher A Reilly; Hamidreza Ghandehari
Journal:  J Pharmacol Exp Ther       Date:  2018-11-15       Impact factor: 4.030

Review 2.  Genetic and Covalent Protein Modification Strategies to Facilitate Intracellular Delivery.

Authors:  Justin M Horn; Allie C Obermeyer
Journal:  Biomacromolecules       Date:  2021-12-02       Impact factor: 6.978

3.  Engineered Interactions with Mesoporous Silica Facilitate Intracellular Delivery of Proteins and Gene Editing.

Authors:  Bin Liu; Wardah Ejaz; Shuai Gong; Myrat Kurbanov; Mine Canakci; Francesca Anson; S Thayumanavan
Journal:  Nano Lett       Date:  2020-04-24       Impact factor: 11.189

4.  Endosomal signaling of delta opioid receptors is an endogenous mechanism and therapeutic target for relief from inflammatory pain.

Authors:  Nestor N Jimenez-Vargas; Jing Gong; Matthew J Wisdom; Dane D Jensen; Rocco Latorre; Alan Hegron; Shavonne Teng; Jesse J DiCello; Pradeep Rajasekhar; Nicholas A Veldhuis; Simona E Carbone; Yang Yu; Cintya Lopez-Lopez; Josue Jaramillo-Polanco; Meritxell Canals; David E Reed; Alan E Lomax; Brian L Schmidt; Kam W Leong; Stephen J Vanner; Michelle L Halls; Nigel W Bunnett; Daniel P Poole
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-16       Impact factor: 11.205

Review 5.  Nanoarchitectured prototypes of mesoporous silica nanoparticles for innovative biomedical applications.

Authors:  Ranjith Kumar Kankala; Ya-Hui Han; Hong-Ying Xia; Shi-Bin Wang; Ai-Zheng Chen
Journal:  J Nanobiotechnology       Date:  2022-03-12       Impact factor: 10.435

6.  Flash Technology-Based Self-Assembly in Nanoformulation: From Fabrication to Biomedical Applications.

Authors:  Hanze Hu; Chao Yang; Mingqiang Li; Dan Shao; Hai-Quan Mao; Kam W Leong
Journal:  Mater Today (Kidlington)       Date:  2020-11-02       Impact factor: 31.041

Review 7.  Drug delivery carriers with therapeutic functions.

Authors:  Shuting S Cai; Tianyu Li; Tolulope Akinade; Yuefei Zhu; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2021-07-21       Impact factor: 17.873

8.  Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers.

Authors:  Jianati Dawulieti; Madi Sun; Yawei Zhao; Dan Shao; Huize Yan; Yeh-Hsing Lao; Hanze Hu; Lianzhi Cui; Xiaoyan Lv; Feng Liu; Chun-Wei Chi; Yue Zhang; Mingqiang Li; Ming Zhang; Huayu Tian; Xuesi Chen; Kam W Leong; Li Chen
Journal:  Sci Adv       Date:  2020-05-29       Impact factor: 14.136

9.  Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy.

Authors:  Tzu-Chieh Ho; Hye Sung Kim; Yumei Chen; Yamin Li; Mark W LaMere; Caroline Chen; Hui Wang; Jing Gong; Cal D Palumbo; John M Ashton; Hae-Won Kim; Qiaobing Xu; Michael W Becker; Kam W Leong
Journal:  Sci Adv       Date:  2021-05-19       Impact factor: 14.136

10.  Nanosilver-Decorated Biodegradable Mesoporous Organosilica Nanoparticles for GSH-Responsive Gentamicin Release and Synergistic Treatment of Antibiotic-Resistant Bacteria.

Authors:  Haijun Li; Dongbei Li; Fangman Chen; Chao Yang; Xiaogai Li; Yuan Zhang; Chunlan Hua; Xiaoxu Ma; Xin Zhao; Dan Shao; Yingshuai Wang; Liang Ming
Journal:  Int J Nanomedicine       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.